Charlene Ranadheera - Publications

Receptor-binding specificity and antigenic properties of a genotype D1.1 A(H5N1) influenza virus isolated from a human.

Journal: Emerging microbes & infections

Published: March 13, 2026

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 06, 2026

Management of critical illness in an adolescent caused by highly pathogenic avian influenza A(H5N1) virus infection in British Columbia, Canada.

Journal: The Lancet. Infectious diseases

Published: November 03, 2025

Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada.

Journal: The Journal of infectious diseases

Published: October 26, 2025

Emergence of seasonal influenza A(H3N2) variants with immune escape potential warrants enhanced molecular and epidemiological surveillance for the 2025-2026 season.

Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

Published: August 28, 2025

Molecular Detection of Various Non-Seasonal, Zoonotic Influenza Viruses Using BioFire FilmArray and GenXpert Diagnostic Platforms.

Journal: Viruses

Published: June 18, 2025

Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024.

Journal: Emerging microbes & infections

Published: February 18, 2025

Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.

Journal: The New England journal of medicine

Published: December 31, 2024

Comparison of fifteen SARS-CoV-2 nucleic acid amplification test assays used during the Canadian Laboratory Response Network's National SARS-CoV-2 Proficiency Program, May 2020 to June 2021.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: February 27, 2024

Evolution of nucleic acid amplification testing across Canada as observed through the Canadian Laboratory Response Network's SARS-CoV-2 Proficiency Test Program, May 2020 to June 2021.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: February 26, 2024

A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1.

Journal: Scientific reports

Published: December 10, 2021

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test.

Journal: Journal of clinical virology plus

Published: March 03, 2021